At Takeda, partnerships are at the heart of what we do. Almost one third* of our revenues come from partnerships and strategic acquisitions, and that will grow to over 50 percent by 2015*. We have significant experience in developing mutually beneficial discovery, development and commercial relationships. Our dedicated alliance management function fosters strong relationships throughout the product life cycle, from early development to late stage. Our teams apply Takeda's core values of perseverance, honesty and fairness to every collaboration.
Takeda has always valued innovation. We have a history of acquiring companies with strong scientific platforms and expertise – Syrxx (now Takeda California), Paradigm Pharmaceuticals (now Takeda Cambridge and Takeda Singapore) and Millennium Pharmaceuticals (now Millennium: The Takeda Oncology Company). We invest in them, allowing them to flourish and achieve their full potential.
Next up AFFY........get your money in now 100% down side 1000%or more upside
Hgsi was down to .35 before it went to 13 .......it held nothing but bad news for 10 months then....bam....affy is no different to the mm......they know the length affy, Takeda, and the fda will take on full outcome of O
Get on board now....we may see a big spike in volume soon with no news driving it other than people know this is getting closer to its outcome . Looking for 2 plus in the next to weeks ...mm will play it this way to cash in on the run up ....